Regor Therapeutics Group

News

Regor Therapeutics Group has agreed to sell its portfolio of CDK inhibitors to Roche's Genentech for an upfront cash payment of $850 million.

News

Moderna saw its Q1 sales nearly triple to $389m, almost a threefold rise on the same period of 2025, with international markets driving the increase.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.